PubRank

G Ostermann

Author PubWeight™ 15.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hospital readmission after transvenous cardioverter/defibrillator implantation; a single centre study. Eur Heart J 2000 1.62
2 Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements. FASEB J 2001 1.33
3 Non-random distribution of mutations in the PHEX gene, and under-detected missense mutations at non-conserved residues. Eur J Hum Genet 1999 1.00
4 Cytohesin-1 is a dynamic regulator of distinct LFA-1 functions in leukocyte arrest and transmigration triggered by chemokines. Curr Biol 2001 0.93
5 [Kinetics of diltiazem in voluntary overdosage]. Presse Med 1984 0.87
6 Different coupling for the reach and grasp components in bimanual prehension movements. Neuroreport 2000 0.85
7 Appendicectomy in an unusual case of lead poisoning. Lancet 1986 0.83
8 The role of lipoproteins in the degradation of platelet-activating factor. Thromb Res 1986 0.82
9 Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor. Thromb Res 1983 0.81
10 Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis. Folia Haematol Int Mag Klin Morphol Blutforsch 1988 0.80
11 Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor. Thromb Res 1987 0.80
12 Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets. Thromb Res 1984 0.79
13 [Cardiac manifestations of pheochromocytoma. Anatomo-clinical study]. Arch Mal Coeur Vaiss 1979 0.79
14 Dual role of H-Ras in regulation of lymphocyte function antigen-1 activity by stromal cell-derived factor-1alpha: implications for leukocyte transmigration. Mol Biol Cell 2001 0.78
15 Apolipoproteins as risk indicators of ischemic heart disease. Przegl Lek 1989 0.78
16 Possible role of alpha 1- and alpha 2-adrenoceptors in the modulation of the sympathetic component of the baroreflex. Neuropharmacology 1983 0.77
17 Central alpha 1-adrenoceptors and cardiovascular control in normotensive and spontaneously hypertensive rats. Eur J Pharmacol 1983 0.77
18 [Predictive value of the exercise test for multivessel disease after initial myocardial infarction]. Arch Mal Coeur Vaiss 1982 0.76
19 [Diabetic cardiac autonomic neuropathy]. Journ Annu Diabetol Hotel Dieu 1984 0.75
20 [Assay of fructosamine. Value and limits in diabetology]. Ann Biol Clin (Paris) 1989 0.75
21 [Synthesis and biological activity of isomeric structural analogs of platelet activating factor]. Pharmazie 1985 0.75
22 Enhanced degradation of platelet-activating factor in serum from diabetic patients. Haemostasis 1989 0.75
23 Further investigations on the alpha 1-adrenoceptor blocking properties of AR-C 239 in rats. Clin Exp Pharmacol Physiol 1986 0.75
24 Modification of the polar head group of platelet-activating factor: influence on the biological activity. Chem Phys Lipids 1987 0.75
25 Halo lipids. VI. Stimulation of human and rabbit blood platelets by racemic halo analogues of O-alkyl-glycerophosphocholine. Biomed Biochim Acta 1984 0.75
26 Effects of synthetic analogues of platelet-activating factor (PAF) on fibrinolytic activity in the rat. Biomed Biochim Acta 1988 0.75
27 [Self-regulation and self-monitoring of blood glucose in diabetics]. Journ Annu Diabetol Hotel Dieu 1983 0.75
28 [Examples of the use of relaxation and suggestion in our hospital experience in cardiology]. Actual Odontostomatol (Paris) 1983 0.75
29 [Influence of thyroid dysfunction on pharmacokinetics and pharmacodynamics of drugs]. Therapie 1988 0.75
30 [Diagnostic value of serum lipid and apolipoprotein parameters for the detection of a coronary risk even in the range of nonpathological serum cholesterol and triglyceride values]. Z Med Lab Diagn 1988 0.75
31 [PAF-antagonists with phospholipid structure. 4. Alkylcarbamoylphospholipids with heteroarene and heterocyclase head groups and variation of the P-N-distance; synthesis, characterization and structure-activity relationship]. Pharmazie 1992 0.75
32 Blood platelet behaviour in patients with a type I diabetes mellitus. Exp Clin Endocrinol 1989 0.75
33 Synthesis and proaggregatory activity of 1-O-(2-methyloctadecyl)-2-O-acetyl-rac-glycero-3-phosphocholine. Chem Phys Lipids 1991 0.75
34 [PAF-antagonists with a phospholipid structure. 1. Phospholipids with hetero-arene head groups: synthesis, characterization and determination of the action of structural elements]. Pharmazie 1991 0.75
35 [Effects of a fully balanced synthetic diet on physical efficiency (author's transl)]. MMW Munch Med Wochenschr 1976 0.75
36 The effect of diamide (azodicarboxylic acid-bis-dimethylamide) on sulfhydryl group content, proteins, and the location of phosphatidylethanolamine in human blood platelets. Acta Haematol 1982 0.75
37 Platelet lysis during aggregation in saline media. Acta Biol Med Ger 1981 0.75
38 Effect of specific antagonists on PAF-induced platelet aggregation and release of plasminogen activator. Biomed Biochim Acta 1988 0.75
39 [Synthesis and thrombocyte aggregating action of stereoisomers of PAF-acether]. Pharmazie 1986 0.75
40 [Apropos of a case of lead colic linked to the ingestion of lead shot]. Rev Med Interne 1988 0.75
41 [Insulin-requiring diabetes]. Diabete Metab 1989 0.75
42 Proaggregatory and inhibitory effects of 2-O-ethyl analogues of platelet-activating factor (PAF) on human and rabbit platelets. Thromb Res 1988 0.75
43 [Evaluation of 50 months' intensive drug monitoring in an internal medicine department with a cardiologic orientation. Prospective study]. Therapie 1984 0.75
44 [Possible regulatory importance of cellular sulfhydryl groups and reduction metabolic pathways for the activation of human blood platelets]. Z Gesamte Inn Med 1984 0.75
45 Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues. Biomed Biochim Acta 1985 0.75
46 [Megakaryocytic myelosis--clinical aspects, morphology and platelet function]. Klin Wochenschr 1989 0.75
47 Stimulation and desensitization of human and rabbit platelets by 1-O-hexadecyl-2-O-methyl-rac-glycero-3-phosphocholine and analogues. Thromb Res 1986 0.75
48 The influence of PAF on the metabolization of arachidonic acid by human blood platelets. Biomed Biochim Acta 1984 0.75
49 Anticoagulant-free preparation of platelets from human native blood--a methodical and morphological report. Thromb Res 1980 0.75
50 [PAF-antagonists with phospholipid structure. 2. Phospholipids with heteroarene head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationships]. Pharmazie 1991 0.75
51 [Synthesis and platelet aggregating activity of structural analogs of platelet-activating factor with a heterocyclic head group]. Pharmazie 1987 0.75
52 [Contact (prekallikrein) and fibrinolytic (plasminogen/antiplasmin value) system in the physiopathology of vascular complications of diabetes]. J Mal Vasc 1982 0.75
53 [Antihypertensive action of acetbutolol. Pharmacokinetic correlation and medium-term fate]. Nouv Presse Med 1978 0.75
54 [Synthesis and biologic activity of some stable structure analogs of platelet activating factor]. Pharmazie 1985 0.75
55 Effects of the synthetic ether phospholipid KO-286011 on cells and components of rabbit blood. Haemostasis 1991 0.75
56 [Aggregative behavior and calcium content of platelets in thrombocythemia and thrombocytosis]. Folia Haematol Int Mag Klin Morphol Blutforsch 1990 0.75
57 [Aneurysm of the interauricular septum: a potential cause of emboligenic cardiopathy]. Ann Med Interne (Paris) 1989 0.75
58 [Left subclavian artery isolated from the aorta on a right aortic arch. Apropos of 2 cases associated with facial anomalies]. Arch Mal Coeur Vaiss 1980 0.75
59 [Plasma digoxin assay. Comparative study of 3 analytic methods]. Ann Biol Clin (Paris) 1984 0.75
60 [Blood digoxin-toxicity and blood digoxin-clinical efficacy relations in elderly patients]. Therapie 1986 0.75
61 [Placebo effect]. Rev Infirm 1987 0.75
62 [Preparation of human platelets without the use of anticoagulants and study of the effect of Catt on aggregation]. Folia Haematol Int Mag Klin Morphol Blutforsch 1979 0.75
63 [PAF-antagonists with phospholipid structure. 3. Phospholipids with heterocyclane head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationship]. Pharmazie 1991 0.75
64 [Synthesis and thrombocyte-aggregating action of a structural analog of platelet activating factor with a modified head group]. Pharmazie 1988 0.75
65 [Cough induced by converting enzyme inhibitors]. Therapie 1987 0.75
66 [Relaxation and hypnosis: "roots and caries"]. Actual Odontostomatol (Paris) 1983 0.75
67 Reconsideration of quantitative phospholipid analysis in human gel-filtered blood platelets. Acta Haematol 1982 0.75
68 Hereditary dysfibrinogenaemia: structural and functional studies on three fibrinogen variants. Folia Haematol Int Mag Klin Morphol Blutforsch 1988 0.75